JP2008531665A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008531665A5 JP2008531665A5 JP2007557572A JP2007557572A JP2008531665A5 JP 2008531665 A5 JP2008531665 A5 JP 2008531665A5 JP 2007557572 A JP2007557572 A JP 2007557572A JP 2007557572 A JP2007557572 A JP 2007557572A JP 2008531665 A5 JP2008531665 A5 JP 2008531665A5
- Authority
- JP
- Japan
- Prior art keywords
- effective amount
- pharmaceutically acceptable
- pharmaceutically effective
- compound
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940125782 compound 2 Drugs 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 241001465754 Metazoa Species 0.000 claims 5
- 239000003085 diluting agent Substances 0.000 claims 5
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims 4
- 102100028626 4-hydroxyphenylpyruvate dioxygenase Human genes 0.000 claims 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 229960004502 levodopa Drugs 0.000 claims 4
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims 3
- 229940123736 Decarboxylase inhibitor Drugs 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003954 decarboxylase inhibitor Substances 0.000 claims 2
- 229940099362 Catechol O methyltransferase inhibitor Drugs 0.000 claims 1
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000007900 aqueous suspension Substances 0.000 claims 1
- 239000003543 catechol methyltransferase inhibitor Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000007902 hard capsule Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- OUBCNLGXQFSTLU-UHFFFAOYSA-N nitisinone Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1C(=O)C1C(=O)CCCC1=O OUBCNLGXQFSTLU-UHFFFAOYSA-N 0.000 claims 1
- 239000012053 oil suspension Substances 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0504103.3A GB0504103D0 (en) | 2005-02-28 | 2005-02-28 | Novel method |
| PCT/GB2006/000684 WO2006090177A1 (en) | 2005-02-28 | 2006-02-27 | USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008531665A JP2008531665A (ja) | 2008-08-14 |
| JP2008531665A5 true JP2008531665A5 (cg-RX-API-DMAC7.html) | 2009-03-12 |
Family
ID=34430351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007557572A Pending JP2008531665A (ja) | 2005-02-28 | 2006-02-27 | パーキンソン病の治療における２−（２−ニトロ−４−トリフルオロメチルベンゾイル）−１，３−シクロヘキサンジオンの使用 |
Country Status (17)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101669432B1 (ko) * | 2007-08-27 | 2016-10-26 | 다트 뉴로사이언스 (케이만) 엘티디. | 치료적 이속사졸 화합물 |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| BRPI0921431A2 (pt) * | 2008-11-06 | 2017-06-06 | Biotie Therapies Ag | método para tratar ou prevenir síndrome das pernas inquietas, composição farmacêutica, e, métodos para tratar ou prevenir distúrbios do sono, e para melhorar a quantidade do sono ou adequação do sono |
| HRP20160286T1 (hr) * | 2011-06-23 | 2016-05-06 | Swedish Orphan Biovitrum International Ab | Tekuća farmaceutska kompozicija koja sadrži nitizinon |
| CN103622942A (zh) * | 2013-11-04 | 2014-03-12 | 江苏大学 | 左旋多巴/卡比多巴复方缓释混悬剂及其制备方法 |
| EP3328381A1 (en) * | 2015-07-29 | 2018-06-06 | Takeda GmbH | Pde4 inhibitor for the treatment of diabetic nephropathy |
| ITUB20160650A1 (it) | 2016-02-11 | 2017-08-11 | Dipharma S A | Formulazioni farmaceutiche solide stabili contenenti 2-(2-nitro-4-trifluorometilbenzoil)-1,3-cicloesandione |
| US9783485B1 (en) | 2016-11-30 | 2017-10-10 | Dipharma S.A. | Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4780127A (en) * | 1982-03-25 | 1988-10-25 | Stauffer Chemical Company | Certain 2-(substituted benzoyl)-1,3-cyclohexanediones and their use as herbicides |
| US5092919A (en) * | 1991-01-15 | 1992-03-03 | Imperial Chemical Industries Plc | Certain 2-(2'-methyl-3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones |
| WO1993000080A1 (en) * | 1991-06-24 | 1993-01-07 | Zeneca Ltd. | Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
| FR2777781B1 (fr) * | 1998-04-24 | 2004-04-09 | Rhone Poulenc Rorer Sa | Associations riluzole et l-dopa pour le traitement de la maladie de parkinson |
| US20050288187A1 (en) * | 2002-07-03 | 2005-12-29 | Hanauske-Abel Hartmut M | Inhibitor development for 4-hydroxyphenylpyruvate dioxygenase, employing tyrosinemia 1 as a model for human diseases mediated by 2-oxoacid utilizing dioxygenases |
| US20060166972A1 (en) * | 2003-07-11 | 2006-07-27 | Conn P J | Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |
| JP2010501532A (ja) * | 2006-08-18 | 2010-01-21 | シンジェンタ リミテッド | うつ病、および／または常習性薬物の使用に伴う禁断症状の治療のための、ｈｐｐｄ阻害薬の使用 |
| BRPI0921431A2 (pt) * | 2008-11-06 | 2017-06-06 | Biotie Therapies Ag | método para tratar ou prevenir síndrome das pernas inquietas, composição farmacêutica, e, métodos para tratar ou prevenir distúrbios do sono, e para melhorar a quantidade do sono ou adequação do sono |
-
2005
- 2005-02-28 GB GBGB0504103.3A patent/GB0504103D0/en not_active Ceased
-
2006
- 2006-02-27 CA CA002598517A patent/CA2598517A1/en not_active Abandoned
- 2006-02-27 PT PT06709910T patent/PT1853241E/pt unknown
- 2006-02-27 RU RU2007131934/15A patent/RU2420272C2/ru not_active IP Right Cessation
- 2006-02-27 AU AU2006217650A patent/AU2006217650B2/en not_active Ceased
- 2006-02-27 WO PCT/GB2006/000684 patent/WO2006090177A1/en not_active Ceased
- 2006-02-27 AT AT06709910T patent/ATE524171T1/de active
- 2006-02-27 ES ES06709910T patent/ES2374761T3/es active Active
- 2006-02-27 ZA ZA200707486A patent/ZA200707486B/xx unknown
- 2006-02-27 DK DK06709910.1T patent/DK1853241T3/da active
- 2006-02-27 US US12/090,645 patent/US20090326072A1/en not_active Abandoned
- 2006-02-27 CN CN2006800133878A patent/CN101163466B/zh not_active Expired - Fee Related
- 2006-02-27 BR BRPI0609177-6A patent/BRPI0609177A2/pt not_active IP Right Cessation
- 2006-02-27 JP JP2007557572A patent/JP2008531665A/ja active Pending
- 2006-02-27 EP EP06709910A patent/EP1853241B1/en active Active
- 2006-02-27 MX MX2007010480A patent/MX2007010480A/es not_active Application Discontinuation
-
2007
- 2007-08-21 IL IL185410A patent/IL185410A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259851A (en) | Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders | |
| WO2007131005A3 (en) | Use of organic compounds | |
| JP2009541489A5 (cg-RX-API-DMAC7.html) | ||
| CY1121781T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων | |
| EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
| JP2004307506A5 (cg-RX-API-DMAC7.html) | ||
| JP2006526031A5 (cg-RX-API-DMAC7.html) | ||
| CN109982699A (zh) | 一种mor激动剂与kor激动剂的药物组合物及其用途 | |
| JP2013541514A5 (cg-RX-API-DMAC7.html) | ||
| JP2013525444A5 (cg-RX-API-DMAC7.html) | ||
| JP2008302206A5 (cg-RX-API-DMAC7.html) | ||
| IL192150A (en) | Use of 2-amino-2- [4- (3-benzyloxyphenylthio) -2-chlorophyll} ethyl-1,3-propanadiol, or its acceptable medical salt or hydrate, for the preparation or treatment of inflammatory bowel disease | |
| JP2011527299A5 (cg-RX-API-DMAC7.html) | ||
| JP2009535370A5 (cg-RX-API-DMAC7.html) | ||
| WO2008053446A3 (en) | Benzoxazepine compounds, their preparation and use | |
| JP2008531665A5 (cg-RX-API-DMAC7.html) | ||
| JP2004532828A5 (cg-RX-API-DMAC7.html) | ||
| IL185410A0 (en) | Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of parkinson's disease | |
| CN115916350A (zh) | Akt抑制剂的单位剂量组合物 | |
| JP2008513426A5 (cg-RX-API-DMAC7.html) | ||
| JP2011068692A5 (cg-RX-API-DMAC7.html) | ||
| MX2010001702A (es) | Farmaco para aliviar las complicaciones motoras o los sintomas psiquiatricos de la enfermedad de parkinson. | |
| JP2012532197A5 (cg-RX-API-DMAC7.html) | ||
| JP2007519646A5 (cg-RX-API-DMAC7.html) | ||
| WO2008120617A1 (ja) | クローン病に伴う腸管狭窄の進展抑制用医薬組成物 |